Estee Lauder Companies Inc (EL) stock
ELNYSEPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Aug 19, 2026Score 8/30132% above fair value
$109.23+0.42 (+0.39%)
Close on Oct 30, 2026Market cap $39.52BP/E 218.5Yield 1.28%
Earnings
Estee Lauder Companies's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
Oct 29, 2026
Q1 FY2027 · estimated, before the open
Revenue, Q4 FY2026
$3.63B
+6.3% on a year earlier
Adjusted EPS, Q4 FY2026
–
-$1.51 a year earlier
Latest guidance
Raised
Aug 19, 2026 · 9 items
Quarterly results
Revenue and earnings per share from each of Estee Lauder Companies's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q1 FY2027ended Sep 30, 2026 | Oct 29, 2026Expected | – | – | – | – | – |
| Q4 FY2026ended Jun 30, 2026 | Aug 19, 2026before the open | $3.63B | +6.3% | – | – | Release |
| Q3 FY2026ended Mar 31, 2026 | May 1, 2026before the open | $3.71B | +3.1% | – | – | Release |
| Q2 FY2026ended Dec 31, 2025 | Feb 5, 2026before the open | $4.20B | +5.0% | – | – | Release |
| Q1 FY2026ended Sep 30, 2025 | Oct 30, 2025before the open | $3.50B | +4.2% | – | – | Release |
| Q4 FY2025ended Jun 30, 2025 | Aug 20, 2025before the open | $3.41B | -11.9% | -$1.51 | – | Release |
| Q3 FY2025ended Mar 31, 2025 | May 1, 2025before the open | $3.60B | -8.6% | – | – | Release |
| Q2 FY2025ended Dec 31, 2024 | Feb 4, 2025before the open | $4.00B | -6.5% | -$1.64 | – | Release |
| Q1 FY2025ended Sep 30, 2024 | Oct 31, 2024before the open | $3.36B | -4.5% | – | – | Release |
| Q4 FY2024ended Jun 30, 2024 | Aug 19, 2024before the open | $3.87B | +7.2% | – | – | Release |
| Q3 FY2024ended Mar 31, 2024 | May 1, 2024before the open | $3.94B | +5.1% | – | – | Release |
| Q2 FY2024ended Dec 31, 2023 | Feb 5, 2024before the open | $4.28B | -7.4% | $0.87 | – | Release |
| Q1 FY2024ended Sep 30, 2023 | Nov 1, 2023before the open | $3.52B | -10.4% | – | – | Release |
| Q4 FY2023ended Jun 30, 2023 | Aug 18, 2023before the open | $3.61B | +1.4% | – | – | Release |
| Q3 FY2023ended Mar 31, 2023 | May 3, 2023before the open | $3.75B | -11.8% | – | – | Release |
| Q2 FY2023ended Dec 31, 2022 | Feb 2, 2023before the open | $4.62B | -16.6% | $1.09 | $1.54 | Release |
| Q1 FY2023ended Sep 30, 2022 | Nov 2, 2022before the open | $3.93B | -10.5% | $1.35 | $1.37 | Release |
| Q4 FY2022ended Jun 30, 2022 | Aug 18, 2022before the open | $3.56B | – | – | – | Release |
| Q3 FY2022ended Mar 31, 2022 | May 3, 2022before the open | $4.25B | – | $1.53 | $1.90 | Release |
| Q2 FY2022ended Dec 31, 2021 | Feb 3, 2022before the open | $5.54B | – | $2.97 | $3.01 | Release |
| Q1 FY2022ended Sep 30, 2021 | Nov 2, 2021before the open | $4.39B | – | $1.88 | $1.89 | Release |
| Q4 FY2021ended Jun 30, 2021 | Aug 19, 2021before the open | – | – | – | – | Release |
| Q3 FY2021ended Mar 31, 2021 | May 3, 2021before the open | – | – | – | – | Release |
| Q2 FY2021ended Dec 31, 2020 | Feb 5, 2021before the open | – | – | – | – | Release |
| Q1 FY2021ended Sep 30, 2020 | Nov 2, 2020before the open | – | – | – | – | Release |
| Q4 FY2020ended Jun 30, 2020 | Aug 20, 2020before the open | – | – | – | – | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Estee Lauder Companies's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| As Reported and Organic net sales growth | FY2027 | +3% – +5% | – | New | May 1, 2026 |
| Net Sales Growth As Reported - GAAPGAAP | FY2027 | +3% – +5% | – | New | Aug 19, 2026 |
| Organic, Non-GAAPnon-GAAP | FY2027 | +3% – +5% | – | New | Aug 19, 2026 |
| Adjusted operating marginnon-GAAP | FY2027 | 12.7% – 13.5% | 12.5% – 13% | Raised | Aug 19, 2026 |
| Forecasted/As Reported EPS - GAAPGAAP | FY2027 | $2.52 – $2.85 | – | New | Aug 19, 2026 |
| Forecasted/Adjusted EPS - Non-GAAPnon-GAAP | FY2027 | $3.10 – $3.35 | – | New | Aug 19, 2026 |
| Capital expenditures | FY2027 | 4% | – | New | Aug 19, 2026 |
| adjusted effective tax ratenon-GAAP | FY2027 | 33% – 34% | – | New | Aug 19, 2026 |
| Net cash flows provided by operating activities | FY2027 | $1.30B – $1.40B | – | New | Aug 19, 2026 |
Guidance vs results
The last range Estee Lauder Companies gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2026 | Revenue growth | +4% | +4.65%Σ4Q | Above range |
| FY2025 | Revenue growth | -9% – -8% | -7.94%Σ4Q | Above range |
| Q3 FY2025 | Revenue growth | -12% – -10% | -8.63% | Above range |
| Q1 FY2025 | Revenue growth | -5% – -3% | -4.55% | Within range |
| Q4 FY2024 | Revenue growth | +5% – +9% | +7.2% | Within range |
| Q3 FY2024 | Revenue growth | +3% – +5% | +5.07% | Above range |
| Q2 FY2024 | Revenue growth | -11% – -9% | -7.36% | Above range |
| Q1 FY2024 | Revenue growth | -12% – -10% | -10.43% | Within range |
| Q3 FY2023 | Revenue growth | -14% – -12% | -11.76% | Above range |
| Q2 FY2023 | diluted net earnings per common share | $1.19 – $1.29 | $1.54 | Above range |
| Q2 FY2023 | EPS (GAAP) | $1.14 – $1.26 | $1.09 | Below range |
| Q2 FY2023 | Revenue growth | -19% – -17% | -16.61% | Above range |
| Q1 FY2023 | diluted net earnings per common share | $1.22 – $1.32 | $1.37 | Above range |
| Q1 FY2023 | EPS (GAAP) | $1.16 – $1.28 | $1.35 | Above range |
| Q1 FY2023 | Revenue growth | -10% – -8% | -10.48% | Below range |
| Q3 FY2022 | diluted net earnings per common share | $1.55 – $1.65 | $1.90 | Above range |
| Q3 FY2022 | EPS (GAAP) | $1.51 – $1.63 | $1.53 | Within range |
| Q2 FY2022 | diluted net earnings per common share | $2.51 – $2.61 | $3.01 | Above range |
| Q2 FY2022 | EPS (GAAP) | $2.47 – $2.59 | $2.97 | Above range |
Guidance history
Every forecast Estee Lauder Companies put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Aug 19, 2026 | Capital expenditures | FY2027 | 4% | New |
| Aug 19, 2026 | Forecasted/Adjusted EPS - Non-GAAP | FY2027 | $3.10 – $3.35 | New |
| Aug 19, 2026 | Forecasted/Adjusted Constant Currency EPS - Non-GAAP | FY2027 | $3.06 – $3.31 | Lowered |
| Aug 19, 2026 | Forecasted/As Reported EPS - GAAP | FY2027 | $2.52 – $2.85 | New |
| Aug 19, 2026 | Adjusted operating margin | FY2027 | 12.7% – 13.5% | Raised |
| Aug 19, 2026 | adjusted effective tax rate | FY2027 | 33% – 34% | New |
| Aug 19, 2026 | Net cash flows provided by operating activities | FY2027 | $1.30B – $1.40B | New |
| Aug 19, 2026 | Net Sales Growth As Reported - GAAP | FY2027 | +3% – +5% | New |
| Aug 19, 2026 | Organic, Non-GAAP | FY2027 | +3% – +5% | New |
| May 1, 2026 | Capital expenditures | FY2026 | 4% | Reaffirmed |
| May 1, 2026 | Adjusted diluted net earnings per common share | FY2026 | $2.35 – $2.45 | Raised |
| May 1, 2026 | Forecasted EPS - GAAP | FY2026 | $0.69 – $0.83 | Lowered |
| May 1, 2026 | Adjusted gross margin | FY2026 | 75% | New |
| May 1, 2026 | Adjusted operating margin | FY2026 | 10.7% – 11% | Raised |
| May 1, 2026 | Adjusted operating margin | FY2027 | 12.5% – 13% | New |
| May 1, 2026 | Net cash flows provided by operating activities | FY2026 | $1.40B – $1.50B | New |
| May 1, 2026 | As Reported - GAAP Net Sales Growth | FY2026 | +4% | Narrowed |
| May 1, 2026 | Organic net sales growth | FY2026 | +3% | Raised |
| May 1, 2026 | As Reported and Organic net sales growth | FY2027 | +3% – +5% | New |
| Feb 5, 2026 | Forecasted/Adjusted EPS - Non-GAAP | FY2026 | $2.05 – $2.25 | Raised |
| Feb 5, 2026 | Forecasted/As Reported EPS - GAAP | FY2026 | $0.98 – $1.22 | Lowered |
| Feb 5, 2026 | Adjusted operating margin | FY2026 | 9.8% – 10.2% | Raised |
| Feb 5, 2026 | Net cash flows provided by operating activities | FY2026 | $1.10B – $1.20B | Raised |
| Feb 5, 2026 | As Reported - GAAP | FY2026 | +3% – +5% | Raised |
| Feb 5, 2026 | Organic, Non-GAAP | FY2026 | +1% – +3% | Raised |
| Oct 30, 2025 | Forecasted/Adjusted EPS - Non-GAAP | FY2026 | $1.90 – $2.10 | Reaffirmed |
| Oct 30, 2025 | Forecasted/Adjusted Constant Currency EPS - Non-GAAP | FY2026 | $1.87 – $2.07 | Lowered |
| Oct 30, 2025 | Forecasted EPS - GAAP | FY2026 | $1.39 – $1.65 | Lowered |
| Oct 30, 2025 | Net Sales Growth As Reported - GAAP | FY2026 | +2% – +5% | Reaffirmed |
| Oct 30, 2025 | Organic Net Sales Growth, Non-GAAP | FY2026 | 0% – +3% | Reaffirmed |
| Aug 20, 2025 | Capital expenditures | FY2026 | 4% | New |
| Aug 20, 2025 | Forecasted/Adjusted EPS - Non-GAAP | FY2026 | $1.90 – $2.10 | New |
| Aug 20, 2025 | Forecasted/As Reported EPS - GAAP | FY2026 | $1.63 – $1.87 | New |
| Aug 20, 2025 | Adjusted operating margin | FY2026 | 9.4% – 9.9% | New |
| Aug 20, 2025 | Net cash flows provided by operating activities | FY2026 | $1.00B – $1.10B | New |
| Aug 20, 2025 | Net Sales Growth - As Reported - GAAP | FY2026 | +2% – +5% | New |
| Aug 20, 2025 | Organic Net Sales Growth | FY2026 | 0% – +3% | New |
| May 1, 2025 | Forecasted/Adjusted EPS - Non-GAAP | FY2025 | $1.30 – $1.55 | New |
| May 1, 2025 | Forecasted/Adjusted Constant Currency EPS - Non-GAAP | FY2025 | $1.33 – $1.58 | Raised |
| May 1, 2025 | Forecasted/As Reported EPS - GAAP | FY2025 | -$1.89 – -$1.61 | New |
| May 1, 2025 | Adjusted gross margin | FY2025 | 73.5% | New |
| May 1, 2025 | effective tax rate | FY2025 | 38% | New |
| May 1, 2025 | Net Sales Growth - As Reported - GAAP | FY2025 | -9% – -8% | New |
| May 1, 2025 | Organic Net Sales Growth | FY2025 | -9% – -8% | New |
| Feb 4, 2025 | effective tax rate | Q3 FY2025 | 36% | New |
| Feb 4, 2025 | As Reported - GAAP net sales growth | Q3 FY2025 | -12% – -10% | New |
| Feb 4, 2025 | Organic, Non-GAAP net sales growth | Q3 FY2025 | -10% – -8% | New |
| Oct 31, 2024 | Reported and organic net sales | Q2 FY2025 | -8% – -6% | New |
| Aug 19, 2024 | Capital expenditures | FY2025 | 5% – 5.5% | New |
| Aug 19, 2024 | diluted net earnings per common share | FY2025 | $2.75 – $2.95 | New |
| Aug 19, 2024 | Reported diluted net earnings per common share | FY2025 | $2.52 – $2.76 | New |
| Aug 19, 2024 | adjusted operating margin | FY2025 | 11% – 11.5% | New |
| Aug 19, 2024 | effective tax rate | FY2025 | 32% | New |
| Aug 19, 2024 | Net cash flows provided by operating activities | FY2025 | $1.80B – $2.00B | New |
| Aug 19, 2024 | Reported net sales | Q1 FY2025 | -5% – -3% | New |
| Aug 19, 2024 | organic net sales | Q1 FY2025 | -5% – -3% | New |
| Aug 19, 2024 | Reported net sales | FY2025 | -1% – +2% | New |
| Aug 19, 2024 | organic net sales | FY2025 | -1% – +2% | New |
| May 1, 2024 | diluted net earnings per common share | FY2024 | $2.14 – $2.24 | Raised |
| May 1, 2024 | Reported diluted net earnings per common share | FY2024 | $1.96 – $2.09 | Lowered |
| May 1, 2024 | Reported net sales | Q4 FY2024 | +5% – +9% | New |
| May 1, 2024 | Organic net sales | Q4 FY2024 | +6% – +10% | New |
| May 1, 2024 | Reported net sales | FY2024 | -3% – -2% | Lowered |
| May 1, 2024 | Organic net sales | FY2024 | -2% – -1% | Lowered |
| Feb 5, 2024 | diluted net earnings per common share | FY2024 | $2.08 – $2.23 | Lowered |
| Feb 5, 2024 | Reported diluted net earnings per common share | FY2024 | $2.04 – $2.20 | Lowered |
| Feb 5, 2024 | Reported net sales | Q3 FY2024 | +3% – +5% | New |
| Feb 5, 2024 | Organic net sales | Q3 FY2024 | +4% – +6% | New |
| Feb 5, 2024 | Reported net sales | FY2024 | -1% – +1% | Raised |
| Feb 5, 2024 | Organic net sales | FY2024 | -1% – +1% | Lowered |
| Nov 1, 2023 | diluted net earnings per common share | FY2024 | $2.17 – $2.42 | Lowered |
| Nov 1, 2023 | Reported diluted net earnings per common share | FY2024 | $2.08 – $2.35 | Lowered |
| Nov 1, 2023 | effective tax rate | FY2024 | 28% | New |
| Nov 1, 2023 | Reported net sales | Q2 FY2024 | -11% – -9% | New |
| Nov 1, 2023 | Organic net sales | Q2 FY2024 | -10% – -8% | New |
| Nov 1, 2023 | Reported net sales | FY2024 | -2% – +1% | Lowered |
| Nov 1, 2023 | Organic net sales | FY2024 | -1% – +2% | Lowered |
| Aug 18, 2023 | diluted net earnings per common share | FY2024 | $3.50 – $3.75 | New |
| Aug 18, 2023 | Reported diluted net earnings per common share | FY2024 | $3.43 – $3.70 | New |
| Aug 18, 2023 | Reported net sales | Q1 FY2024 | -12% – -10% | New |
| Aug 18, 2023 | organic net sales | Q1 FY2024 | -12% – -10% | New |
| Aug 18, 2023 | Reported net sales | FY2024 | +5% – +7% | New |
| Aug 18, 2023 | Organic net sales | FY2024 | +6% – +8% | New |
| May 3, 2023 | diluted net earnings per common share | FY2023 | $3.29 – $3.39 | Lowered |
| May 3, 2023 | Reported diluted net earnings per common share | FY2023 | $2.62 – $2.76 | Lowered |
| May 3, 2023 | effective tax rate | FY2023 | 27% | Raised |
| May 3, 2023 | Reported net sales | FY2023 | -12% – -10% | Lowered |
| Feb 2, 2023 | diluted net earnings per common share | FY2023 | $4.87 – $5.02 | Lowered |
| Feb 2, 2023 | Reported diluted net earnings per common share | FY2023 | $4.25 – $4.44 | Lowered |
| Feb 2, 2023 | effective tax rate | FY2023 | 25.5% | Raised |
| Feb 2, 2023 | Reported net sales | Q3 FY2023 | -14% – -12% | New |
| Feb 2, 2023 | Organic net sales | Q3 FY2023 | -10% – -8% | New |
| Feb 2, 2023 | Reported net sales | FY2023 | -7% – -5% | Raised |
| Nov 2, 2022 | diluted net earnings per common share | Q2 FY2023 | $1.19 – $1.29 | New |
| Nov 2, 2022 | diluted net earnings per common share | FY2023 | $5.25 – $5.40 | Lowered |
| Nov 2, 2022 | Reported diluted net earnings per common share | Q2 FY2023 | $1.14 – $1.26 | New |
| Nov 2, 2022 | Reported diluted net earnings per common share | FY2023 | $5.01 – $5.21 | Lowered |
| Nov 2, 2022 | effective tax rate | FY2023 | 25% | Raised |
| Nov 2, 2022 | Reported net sales | Q2 FY2023 | -19% – -17% | New |
| Nov 2, 2022 | Organic net sales | Q2 FY2023 | -11% – -9% | New |
| Nov 2, 2022 | Reported net sales | FY2023 | -8% – -6% | Lowered |
| Aug 18, 2022 | capital expenditures | FY2023 | 6.5% | New |
| Aug 18, 2022 | diluted net earnings per common share | Q1 FY2023 | $1.22 – $1.32 | New |
| Aug 18, 2022 | diluted net earnings per common share | FY2023 | $7.39 – $7.54 | New |
| Aug 18, 2022 | Reported diluted net earnings per common share | Q1 FY2023 | $1.16 – $1.28 | New |
| Aug 18, 2022 | Reported diluted net earnings per common share | FY2023 | $7.11 – $7.33 | New |
| Aug 18, 2022 | effective tax rate | FY2023 | 23% | New |
| Aug 18, 2022 | Net cash flows provided by operating activities | FY2023 | $3.10B – $3.20B | New |
| Aug 18, 2022 | Reported net sales | Q1 FY2023 | -10% – -8% | New |
| Aug 18, 2022 | Organic net sales | Q1 FY2023 | -6% – -4% | New |
| Aug 18, 2022 | Reported net sales | FY2023 | +3% – +5% | New |
| Aug 18, 2022 | Organic net sales | FY2023 | +7% – +9% | New |
| May 3, 2022 | diluted net earnings per common share | FY2022 | $7.05 – $7.15 | Lowered |
| May 3, 2022 | Reported diluted net earnings per common share | FY2022 | $6.54 – $6.70 | Lowered |
| May 3, 2022 | Reported net sales | FY2022 | +7% – +9% | Lowered |
| May 3, 2022 | Organic net sales | FY2022 | +5% – +7% | Lowered |
| Feb 3, 2022 | diluted net earnings per common share | Q3 FY2022 | $1.55 – $1.65 | New |
| Feb 3, 2022 | diluted net earnings per common share | FY2022 | $7.43 – $7.58 | Raised |
| Feb 3, 2022 | Reported diluted net earnings per common share | Q3 FY2022 | $1.51 – $1.63 | New |
| Feb 3, 2022 | Reported diluted net earnings per common share | FY2022 | $7.28 – $7.47 | Raised |
| Feb 3, 2022 | Reported net sales | Q3 FY2022 | +10% – +12% | New |
| Feb 3, 2022 | Organic net sales | Q3 FY2022 | +8% – +10% | New |
| Feb 3, 2022 | Reported net sales | FY2022 | +13% – +16% | Raised |
| Feb 3, 2022 | Organic net sales | FY2022 | +10% – +13% | Raised |
| Nov 2, 2021 | diluted net earnings per common share | Q2 FY2022 | $2.51 – $2.61 | New |
| Nov 2, 2021 | diluted net earnings per common share | FY2022 | $7.23 – $7.38 | New |
| Nov 2, 2021 | Reported diluted net earnings per common share | Q2 FY2022 | $2.47 – $2.59 | New |
| Nov 2, 2021 | Reported diluted net earnings per common share | FY2022 | $7.09 – $7.30 | New |
| Nov 2, 2021 | Reported net sales | Q2 FY2022 | +11% – +13% | New |
| Nov 2, 2021 | Organic net sales | Q2 FY2022 | +8% – +10% | New |
| Nov 2, 2021 | Reported net sales | FY2022 | +12% – +15% | New |
| Nov 2, 2021 | Organic net sales | FY2022 | +9% – +12% | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Estee Lauder Companies filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- News
- Results
- News
- Results
- Results
- Update
- Results
- Results
- Results
- Results
- Results
- News
- Results
- News